---
layout: post
title: "Government-Owned Inventions; Availability for Licensing and Collaboration for Phase 3 Study"
date: 2026-02-05 18:56:06 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-14761
original_published: 2023-07-12 00:00:00 +0000
significance: 8.00
---

# Government-Owned Inventions; Availability for Licensing and Collaboration for Phase 3 Study

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** July 12, 2023 00:00 UTC
**Document Number:** 2023-14761

## Summary

The invention described below will be a first-in-class, reversible, hormonal contraceptive method for males and is co-owned by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, and The Population Council, Inc., a New York not-for-profit corporation based in New York City ("Population Council"). The co-owners will complete the Phase 2b clinical stage of development in 2024 and are seeking a licensee and investor/collaborator for the Phase 3 clinical stage, anticipated to begin as early as 2024.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/07/12/2023-14761/government-owned-inventions-availability-for-licensing-and-collaboration-for-phase-3-study)
- API: https://www.federalregister.gov/api/v1/documents/2023-14761

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
